Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One-week Multicenter, Multiple-dose, Randomized, Double-blind, Double-dummy, Parallel-group Comparison of the Analgesic Efficacy and Safety of Lumiracoxib (COX189), Celecoxib, and Placebo in the Treatment of Osteoarthritis of the Knee

NCT00267215 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00267215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00267215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One-week Multicenter, Multiple-dose, Randomized, Double-blind, Double-dummy, Parallel-group Comparison of the Analgesic Efficacy and Safety of Lumiracoxib (COX189), Celecoxib, and Placebo in the Treatment of Osteoarthritis of the Knee
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2000
Completion date
Not reported
Enrollment
330
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis